Read more
In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.
List of contents
1 Chronic Leukemias: History, Epidemiology, and Risk Factors.- 2 Chronic Lymphocytic Leukemia: Diagnosis and Management.- 3 Hairy Cell Leukemia: Biology, Diagnosis, and Treatment.- 4 Prolymphocytic Leukemias.- 5 Chronic Myeloid Leukemia.- 6 Sézary Syndrome: The Redefinition of a Clinico-Pathologic Entity and its Implication for Staging, Prognosis, and Treatment.- 7 Large Granular Lymphocyte Proliferative Diseases.- 8 Myeloproliferative Syndromes.- 9 Advances in the Biology and Treatment of Multiple Myeloma.- 10 Low-Grade Lymphoma.- 11 Aggressive Large-Cell Lymphomas.- 12 Hodgkin's Disease.
Summary
In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.
Additional text
"The book summarizes well the most recent insights into molecular pathogenesis of chronic hematologic diseases including chronic leukemias, myelo- and lymphoproliferative diseases, lymphomas and multiple myeloma, and their relevance for assessment of prognosis and management decisions. The results of trials evaluating novel targeted therapies are presented, succinctly providing reader with the most current information...This is a very useful book since it covers the most recent achievements and "hot" topics in chronic hematologic diseases in a concise format. The up-to-date information that it provides might not be available in larger textbooks, and thus it is highly recommended for practitioners and researchers." -Doody's Health Sciences Book Review Journal
Report
"The book summarizes well the most recent insights into molecular pathogenesis of chronic hematologic diseases including chronic leukemias, myelo- and lymphoproliferative diseases, lymphomas and multiple myeloma, and their relevance for assessment of prognosis and management decisions. The results of trials evaluating novel targeted therapies are presented, succinctly providing reader with the most current information...This is a very useful book since it covers the most recent achievements and "hot" topics in chronic hematologic diseases in a concise format. The up-to-date information that it provides might not be available in larger textbooks, and thus it is highly recommended for practitioners and researchers." -Doody's Health Sciences Book Review Journal
